Mount Judi Ventures’ Post

Thank you, Manu Rikhye, for the kind words and for believing in us from the very beginning. As founders, we know that building a startup is never a straight path—it’s filled with challenges, uncertainties, and moments where the right support makes all the difference. At 4baseCare, we’ve been incredibly fortunate to have an ecosystem of fantastic early-stage investors like growX ventures / Merak Ventures, Mount Judi Ventures, Season Two Ventures, and First In Ventures, LLC and all our fabulous #AngelInvestors Your belief in our vision, your guidance, and most importantly, your unwavering support during tough times have been instrumental in shaping our journey. This milestone with Infosys is as much yours as it is ours. Together, we’re taking meaningful steps toward transforming #CancerCare to make it more personalized, precise, and patient-centric. Thank you for standing shoulder to shoulder with us as we continue to build for patients who need it the most. Here’s to many more milestones ahead! :-) #StartUp #StartupJourney #HealthTech #CancerCare #Healthcare #Founders #PersonalizedMedicine #Funding #Infosys #PrecisionOncology #4baseCare #Entrepreneurship #EcosystemSupport #Investors #PartnershipsForImpact #Cancer #Oncology #Genomics #DigitalHealth

Exciting developments for 4baseCare, one of our MedTech Innovator Asia Pacific alumni! Infosys has announced an investment of Rs 8.3 crores (approximately $1 million) in 4baseCare through the #InfosysInnovationFund. This partnership will leverage 4baseCare’s expertise in #AI, #DeepTech, and #genomics to advance personalized oncology care and improve patient outcomes. It’s great to see our alumni making strides in #healthcare innovation and driving progress in #precisionmedicine. 🚀 Read more here: https://lnkd.in/gDfAh3Gq #MedTech #digitalhealth #healthtech #diagnostics #MTIAPAC #MTIAPACAlumni #Innovation #Oncology

Infosys invests 8.3 crore in 4baseCare, a healthcare deep-tech startup, acquiring a 20% stake to boost cancer care technology and revolutionize precision oncology, leveraging genomics and digital health tools for personalized care. The partnership combines Infosys' expertise and resources with 4baseCare's tech knowledge and innovative approach to transform healthcare. 4baseCare is a pioneering precision oncology company focused on personalized cancer treatment through Next Generation Sequencing Competence Network (NGS) and digital health technology. Founded in 2018 by Hitesh Goswami and Kshitij Rishi, the startup has garnered significant attention from investors, including Yali Capital and GrowX Ventures. With recent investments from Infosys, the company aims to revolutionize cancer care by leveraging technology and innovation. The partnership between Infosys and 4baseCare signifies the potential for startups and established companies to collaborate effectively in addressing healthcare challenges. This alliance paves the way for smarter, more effective healthcare solutions in the future. Factacy.ai Congratulates and wishes them well. #innovation #management #digitalmarketing #technology #creativity #futurism #startups

Exciting development from Infosys as they acquire a 20% stake in the innovative healthtech startup 4baseCare. The strategic investment of ₹8.3 crore is part of Infosys' Innovation Fund, aimed at assisting clients in navigating business transformations. 4baseCare, renowned for securing $6 million in its Series A funding round, specializes in leveraging state-of-the-art genomics and digital health technologies to offer personalized cancer care solutions. This partnership highlights Infosys' commitment to advancing healthcare technology innovation and supporting 4baseCare's mission of revolutionizing cancer treatment through cutting-edge, patient-centric approaches.

Neuranics, a healthcare diagnostics startup, has successfully raised $700K funding in a seed round led by Inflection Point Ventures (IPV). The funds will be utilised for technology development and clinical validation, enabling the company to accelerate its mission to revolutionize blood diagnostics. https://lnkd.in/da47ZsPm Praveen Kumar Bhagat Ashutosh Patra #diagnosticlab #healthcarestartup

Qure.ai, a prominent healthcare technology company, reported an impressive 83% increase in revenue, reaching Rs 141 crore in FY24. The company also raised $65 million in a funding round led by major investors. Specializing in AI-driven diagnostic tools for detecting critical health conditions like tuberculosis, lung cancer, and stroke, Qure.ai’s solutions contributed 87.23% of its operating revenue. Despite rising expenses, including a 66.2% jump in employee benefits, the company successfully reduced its losses by 38.5% during FY24. As Qure.ai continues to innovate and expand, it is well-positioned for future growth in the healthcare industry. Hashtags: #QureAI #HealthcareInnovation #AIinHealthcare #FundingRound #StartupGrowth #AIStartups #Diagnostics #HealthTech #RevenueGrowth #MedicalTech #FutureOfHealthcare #Startup77

Healthcare diagnostics startup Neuranics has raised $700K in funding in a seed round led by Inflection Point Ventures (IPV). The funds will be utilised for technology development and clinical validation, enabling the company to accelerate its mission to revolutionise blood diagnostics. Head to our website to read more: https://lnkd.in/g_t7JY7h Neuranics Lab Mitesh Shah Dr.Megha Sharma Praveen Kumar Bhagat #indiamedtoday #neuranicslab #healthcare #healthcarenews #halthcareupdates

💰 Cercle, an AI company transforming women’s healthcare data into actionable insights, has raised $6 million in a seed funding round led by Outsiders Fund. Other investors include FemHealth Ventures, CGHealth Ventures, Rogue Women's Fund, and existing backers like Sheryl Sandberg and Tom Bernthal’s SBVP fund. 💸 💬 "Women’s healthcare is under-researched, underfunded, and underserved. Our mission at Cercle is simple and clear: to leverage the power of AI to generate insights from women’s health data in order to drive efficiencies for providers, develop drugs faster, and improve care for patients." Ashley Finch, Co-founder & COO of Cercle #femtech #femhealth #womenshealth #womenshealthinnovation #health #healthcare #healthtech #healthcareinnovation #ai #investment #funding #digitalhealth #startup #venturecapital #vc

Over the past six months, IPV proactively explored strategic options for DCode Care - a Volo Health Company, including potential mergers and acquisitions options with major healthcare players and synergies within our health-tech portfolio. We ultimately facilitated a successful acquihire deal with Volo, enabling them to acquire DCode Care’s team, patents, technology, and customer contracts. Despite the challenges, we stood by DCode Care, ensuring the team's efforts were recognized and our investors' interests were preserved. IPV investors received both cash and shares in Volo Health in exchange for their investment in DCode giving them a second chance to benefit. We have a proven track record of structuring such advantageous transactions in the past. At IPV, we always stand by startups, offering not just capital but also strategic guidance, operational support, and access to a vast network. We immerse ourselves in their vision, helping them navigate challenges, celebrate milestones, and pivot when necessary. We foster a resilient and innovative community for startups to share experiences and collaborate. Simultaneously, we are committed to ensuring that our investors receive returns on their investments through strategic and impactful support. https://lnkd.in/giBgiykn Vinay Bansal | Ankur Mittal | Vinod Bansal | Mitesh Shah | Vikram Ramasubramanian | Ivy Chin | Jay Sampat | Rajeev Kochar | Deepak Chandran | Babita Chopra | Dr. Anand Banka | Rajiv Indimath | Ruchi Pandiya | Dimple Mirchandani | SUMIT BIJAKA | Gaurav Nayak | Sumati Madiman | Sahil Chopra | Latika Arora | Chintan Vyas . | Swarna Gurumurthy | Anil Kumar Siddu | Neha G. | JAYANTH PRAKASH #startups #supporting #ipv #inflectionpointventures

#digital #health #funding Qualified Health Launches with $30M Seed Funding to Develop the Infrastructure for Generative AI in Healthcare Aviceda Therapeutics, a biotech startup developing treatments for inflammation, raised a $207.5 million Series C led by Omega Funds and TCGX. Dublin-based FIRE1 , which develops medical devices to monitor heart failure, raised a $120 million round led by Polaris Partners and Elevage Medical Technologies. Francis Medical, a startup creating treatments for prostate, kidney and bladder cancer, raised an $80 million Series C led by Arboretum Ventures and Solas BioVentures. Biotech startup XyloCor Therapeutics, Inc. Therapeutics, which focuses on cardiovascular disease therapies, raised a $67.5 million Series B led by JEITO Capital. Deciphex, a Dublin-based AI-powered digital pathology startup, closed a €31 million Series A led by Molten Ventures. Senseera, an Israeli liquid biopsy startup, raised a $7.1 million seed investment led by Lightspeed Venture Partners. #digitalhealth #startups #venturecapital